Adams Nager

As long as the administration recognizes the need to continue attracting the world’s best and brightest—and takes a careful, “mend it, don’t end it” approach to carrying out the president’s order—the result can be beneficial for the U.S. economy, writes Adams Nager on MarketWatch.

President Trump assumes crowded out private investment will restore R&D expenditures after deep budget cuts, but evidence disagrees, writes Adams Nager in Innovation Files.

The international community needs to work assiduously to architect a global innovation system supported by innovation-empowering trade rules and well-constructed domestic policies to spur innovation.

It’s time to change the narrative that U.S. manufacturing jobs are being lost to robots in a rapid shift to high-tech “factories of the future” that pushes U.S. manufacturing output to an all-time high, write Adams Nager and Rob Atkinson in IndustryWeek.

Automation was not the primary culprit behind manufacturing job losses, and now too little automation is depressing U.S. output and leading to stagnation in U.S. manufacturing.

The differences in the United States’ relationship with these two nations shows the need for a more nuanced discussion on trade, writes Adams Nager in Innovation Files.

Adams Nager writes in Innovation Files that as the United States celebrates an oil boom, the question must be asked: Is the United States immune to Dutch Disease?

Adams Nager writes in International Economy that the election of Donald Trump was a body blow to the so-called “Washington trade consensus,” a coherent, if intellectually flawed, set of beliefs which holds that trade always benefits the U.S. economy and that any efforts to restrict it, even in the service of ensuring that our trading partners play by the rules, by definition is detrimental to economic growth.

America’s innovation-driven, high-tech economy isn’t concentrated around a few hubs like Silicon Valley; it is widely diffused—and every state and congressional district has a stake in its success.

Too little, not too much, technology may be responsible for slow median wage growth that frustrates voters this election, writes Adams Nager in Innovation Files.

ITIF applauds the intention of the U.S. Department of Homeland Security’s proposed rule on international entrepreneurs, but as currently written, the rule could be applied to individuals and companies that would have negligible impact on U.S. job growth, innovation, and productivity.

Spurring biopharmaceutical innovation to understand and cure brain diseases and disorders could improve health outcomes for more than 50 million Americans while increasing GDP by up to $1.5 trillion or more.

Join ITIF for the release of a new report examining the potential economic gains the United States could reap from biopharma innovation that enables improved diagnosis, treatment, cures, and even prevention of mental and neurological health conditions.